DB
KRRO icon

Dmitry Balyasny’s Korro Bio KRRO Stock Holding History

Dmitry Balyasny’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
951,783
-88,271
-8% -$1.1M 0.02% 957
2026
Q1 		$11.8M Buy
+1,040,054
New +$11.4M 0.02% 963
2025
Q1 		– Sell
-5,778
Closed -$220K – 3058
2024
Q4 		$220K Buy
+5,778
New +$297K ﹤0.01% 2503
2024
Q2 		– Sell
-3,773
Closed -$340K – 2861
2024
Q1 		$340K Buy
+3,773
New +$206K ﹤0.01% 2212
2022
Q4 		– Sell
-235
Closed -$21K – 3013
2022
Q3 		$21K Buy
+235
New +$23.9K ﹤0.01% 2579

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dmitry Balyasny's KRRO Position: Q2 2026 in Review

Dmitry Balyasny reduced its Korro Bio (KRRO) stake by 8.5% in Q2 2026, selling an estimated $1.1M and leaving 951,783 shares worth $12.5M. The position accounts for 0.02% of the portfolio, ranked #957.

Dmitry Balyasny first reported a position in KRRO in Q3 2022 and has held it in 5 quarters since. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Dmitry Balyasny held 951,783 shares of Korro Bio worth $12.5M as of Q2 2026.
  • Dmitry Balyasny sold 88,271 Korro Bio shares in Q2 2026, an estimated $1.1M.
  • Korro Bio made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #957 holding.
  • Dmitry Balyasny first reported a position in Korro Bio in Q3 2022 and has held it in 5 quarters since.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.